Enantioselective Total Synthesis of (+)-Dihydro-β-erythroidine.
Journal
Journal of the American Chemical Society
ISSN: 1520-5126
Titre abrégé: J Am Chem Soc
Pays: United States
ID NLM: 7503056
Informations de publication
Date de publication:
05 06 2019
05 06 2019
Historique:
pubmed:
28
5
2019
medline:
12
9
2020
entrez:
25
5
2019
Statut:
ppublish
Résumé
Erythrina alkaloids represent a rich source of complex polycyclic, bioactive natural products. In addition to their sedative and hypotensive effect, their curare-like activity and structural framework have made them attractive targets for synthetic and medicinal chemists. (+)-Dihydro-β-erythroidine (DHβE), the most potent nicotine acetylcholine receptor antagonist (nAChR) of the Erythrina family, is synthesized for the first time in 13 steps from commercially available material.
Identifiants
pubmed: 31122014
doi: 10.1021/jacs.9b04626
doi:
Substances chimiques
Dihydro-beta-Erythroidine
23255-54-1
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM